Hiroshi Yatsuhashi - Concepedia

Author

Hiroshi Yatsuhashi

Also Known As

Atsumasa Komori, H Tsubouchi, H YATSUHASHI, H Yatsuhashi, H. YATSUHASHI, H. Yatsuhashi, H., Yatsuhashi, HIROSHI YATSUHASHI, Hiroshi YATSUHASHI, Hiroshi Yatsuhashi

366

Publications

10.3K

Citations

H-Index

141

Concepts

All Affiliations

Nagasaki Medical Center Nagasaki University National Center for Global Health and Medicine Musashino Red Cross Hospital Shinshu University

About

Hiroshi Yatsuhashi is an author at Nagasaki Medical Center specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	37	68	4.7K
2	Health Sciences	10	11	1.6K
3	Public Health	4	4	270
4	Engineering	2	2	50
5	Allergy	2	2	29

Hiroshi Yatsuhashi

158

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue, Journal of Hepatology FibrosisHepatologyLiver PhysiologyClinical TrialsPathology	2020	438
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial Masashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, The Lancet Infectious Diseases HepatologyHepatitis CViral HepatitisAntiviral Drug DevelopmentAntiviral Therapy	2015	361
Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis Minoru Nakamura, Hisayoshi Kondo, Tsuyoshi Mori, Hepatology	2006	353
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population Minoru Nakamura, Nao Nishida, Minae Kawashima, The American Journal of Human Genetics Genome-wide Association StudyHepatologyLiver PhysiologyGeneticsGenetic Epidemiology	2012	269
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update Ryosuke Tateishi, Koji Uchino, Naoto Fujiwara, Journal of Gastroenterology	2018	235
Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients Kazumi Yamasaki, Masakuni Tateyama, Seigo Abiru, Hepatology	2014	228
Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection Atsushi Ozasa, Yasuhito Tanaka, Etsuro Orito, Hepatology	2006	221
Serum cytokine and soluble cytokine receptor levels in patients with non‐alcoholic steatohepatitis Seigo Abiru, Kiyoshi Migita, Yümi Maeda, Liver International	2005	204
Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 <scp>HCV</scp> infection: an open‐label, phase 3 trial Masao Omata, Shuhei Nishiguchi, Yoshiyuki Ueno, Journal of Viral Hepatitis Japanese PatientsHcv InfectionHepatologyHepatitis CViral Hepatitis	2014	201
Prospective analysis of risk factors for early intrahepatic recurrence of hepatocellular carcinoma following ethanol injection Khaleque Newaz Khan, Hiroshi Yatsuhashi, Kazumi Yamasaki, Journal of Hepatology HepatologyMedicineLiver PhysiologyPathologyComplications Of Cirrhosis	2000	162

Page 1